Therefore, in the present study, the expression levels of PRDX 1 and PRDX2 were evaluated in bladder cancer tissue and patients' urine, and their association with recurrence on follow-up was evaluated. The gene discussed is PRDX2; the disease is urinary bladder carcinoma.